{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Madunic IV"],"funding":["Deutsche Forschungsgemeinschaft","Hrvatska Zaklada za Znanost"],"pagination":["1545-1565"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5691098"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["469(12)"],"pubmed_abstract":["The expression and localization of sodium-D-glucose cotransporter SGLT1 (SLC5A1), which is involved in small intestinal glucose absorption and renal glucose reabsorption, is of high biomedical relevance because SGLT1 inhibitors are currently tested for antidiabetic therapy. In human and rat organs, detailed expression profiling of SGLT1/Sglt1 mRNA and immunolocalization of the transporter protein has been performed. Using polyspecific antibodies and preabsorption with antigenic peptide as specificity control, in several organs, different immunolocalizations of SGLT1/Sglt1 between human and rat were obtained. Because the preabsorption control does not exclude cross-reactivity with similar epitopes, some localizations remained ambiguous. In the present study, we performed an immunocytochemic"],"journal":["Pflugers Archiv : European journal of physiology"],"pubmed_title":["Expression profiling and immunolocalization of Na<sup>+</sup>-D-glucose-cotransporter 1 in mice employing knockout mice as specificity control indicate novel locations and differences between mice and rats."],"pmcid":["PMC5691098"],"funding_grant_id":["IP-11-2013-1481","KO872/5-1"],"pubmed_authors":["Sabolic I","Madunic IV","Karaica D","Koepsell H","Breljak D"],"additional_accession":[]},"is_claimable":false,"name":"Expression profiling and immunolocalization of Na<sup>+</sup>-D-glucose-cotransporter 1 in mice employing knockout mice as specificity control indicate novel locations and differences between mice and rats.","description":"The expression and localization of sodium-D-glucose cotransporter SGLT1 (SLC5A1), which is involved in small intestinal glucose absorption and renal glucose reabsorption, is of high biomedical relevance because SGLT1 inhibitors are currently tested for antidiabetic therapy. In human and rat organs, detailed expression profiling of SGLT1/Sglt1 mRNA and immunolocalization of the transporter protein has been performed. Using polyspecific antibodies and preabsorption with antigenic peptide as specificity control, in several organs, different immunolocalizations of SGLT1/Sglt1 between human and rat were obtained. Because the preabsorption control does not exclude cross-reactivity with similar epitopes, some localizations remained ambiguous. In the present study, we performed an immunocytochemic","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Dec","modification":"2026-05-02T10:22:51.257Z","creation":"2019-03-27T03:02:16Z"},"accession":"S-EPMC5691098","cross_references":{"pubmed":["28842746"],"doi":["10.1007/s00424-017-2056-1"]}}